Bio Green Med Solution, Inc. (BGMS) vs Liminatus Pharma, Inc. Class A Common Stock (LIMN)
A side-by-side comparison of Bio Green Med Solution, Inc. and Liminatus Pharma, Inc. Class A Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BGMS
Bio Green Med Solution, Inc.
$0.85HealthcareDelayed quote: Oct 6, 2026, 10:27 AM EDT
LIMN
Liminatus Pharma, Inc. Class A Common Stock
$3.88HealthcareDelayed quote: Oct 6, 2026, 10:20 AM EDT
Total return — BGMS vs LIMN
growth of $100 · dividends reinvested · last 1yBGMS -85.6% (-85.6%/yr)LIMN -96.0% (-96.0%/yr)BGMS compounded faster over this window
BGMS LIMN
BGMS vs LIMN: by the numbers
- •LIMN is the larger company ($5M vs $5M market cap).
- •Both run net losses; LIMN's is the smaller (0.00% vs -118.27% net margin).
Metrics side by side
Valuation
| Metric | BGMS | LIMN |
|---|---|---|
| P/S ratio | 2.53 | N/A |
| P/B ratio | 0.66 | 17.31 |
Profitability
| Metric | BGMS | LIMN |
|---|---|---|
| Gross margin | 19.34% | 0.00% |
| Operating margin | -1128.11% | 0.00% |
| Net margin | -118.27% | 0.00% |
| ROE | -30.74% | -4165.92% |
| ROIC | -38.23% | -225.12% |
Go deeper
Dig into the metrics
Bio Green Med Solution ROELiminatus Pharma, Inc. Class A Common Stock ROEBio Green Med Solution operating marginLiminatus Pharma, Inc. Class A Common Stock operating marginBio Green Med Solution revenue growthLiminatus Pharma, Inc. Class A Common Stock revenue growthBio Green Med Solution free cash flowLiminatus Pharma, Inc. Class A Common Stock free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.